Patent details
EP3150256
Title:
COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR
Basic Information
- Publication number:
- EP3150256
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP161850904
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR
- French Title of Invention:
- COMBINAISON D'ANTICORPS ANTI-CD20 ET INHIBITEUR SÉLECTIF PI3 KINASE
- German Title of Invention:
- KOMBINATION VON ANTI-CD20-ANTIKÖRPERN UND PI3-KINASESELEKTIVEM INHIBITOR
- SPC Number:
-
Dates
- Filing date:
- 01/11/2013
- Grant date:
- 15/07/2020
- EP Publication Date:
- 05/04/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/07/2020
- EP B1 Publication Date:
- 15/07/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 01/11/2022
- Expiration date:
- 01/11/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/07/2020
-
-
- Name:
- Laboratoire Français du Fractionnement et des
Biotechnologies
- Address:
- 3, avenue des Tropiques,
ZA Courtaboeuf,, 91940 Les Ulis, France (FR)
- Name:
- Rhizen Pharmaceuticals S.A.
- Address:
- Fritz Courvoisier 40, 2300 La Chaux de Fonds, Switzerland (CH)
- Name:
- TG Therapeutics Inc.
- Address:
- 2 Gransevoort Street, 9th Floor, New York, NY 10014, United States (US)
Agent
- Name:
- NOVAGRAAF BREVETS
- From:
- 05/10/2020
- Address:
- BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
- To:
Inventor
1
- Name:
- Miskin, Hari
- Address:
- United States (US)
2
- Name:
- Sportelli, Peter
- Address:
- United States (US)
3
- Name:
- Weiss, Michael
- Address:
- United States (US)
4
- Name:
- Vakkalanka, Swaroop K.V.S
- Address:
- Switzerland (CH)
Priority
1
- Priority Number:
- 4595CH2012
- Priority Date:
- 02/11/2012
- Priority Country:
- India (IN)
2
- Priority Number:
- 201361771812 P
- Priority Date:
- 02/03/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/519;
A61K 39/395;
A61K 45/06;
A61P 35/00;
A61P 37/00;
C07K 16/28;
Publication
European Patent Bulletin
- Issue number:
- 202029
- Publication date:
- 15/07/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 19/10/2021
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)